Dr Bayliss
@drbayliss.bsky.social
📤 14
📥 28
📝 3
Virotherapy Researcher
pinned post!
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies. Interested in contributing? Please submit an abstract to
app.jove.com/methods-coll...
loading . . .
JoVE Methods Collections
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
https://app.jove.com/methods-collections
6 months ago
0
0
1
reposted by
Dr Bayliss
Alan Parker
2 months ago
A major milestone for Accession Therapeutics, and a fairly huge personal milestone, also.
www.accessiontherapeutics.com/post/accessi...
loading . . .
Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
Accession Therapeutics Limited, a biopharmaceutical company developing next generation cancer immunotherapies, today announced it has dosed the first patient in its Phase I clinical trial evaluating T...
https://www.accessiontherapeutics.com/post/accession-therapeutics-doses-first-patient-in-phase-1-clinical-trial-of-trocept-01-attr-01
0
4
1
Exciting news, and a huge amount of effort and dedication from all involved .
www.cardiff.ac.uk/news/view/29...
loading . . .
First patient recruited in clinical trial using cancer-targeting virus
The ATTEST trial is using a pioneering virus technology to infect cancer cells.
https://www.cardiff.ac.uk/news/view/2987115-first-patient-recruited-in-clinical-trial-using-cancer-targeting-virus
about 2 months ago
0
0
0
reposted by
Dr Bayliss
Alan Parker
about 2 months ago
An incredibly proud moment, and a nice way to wrap up 2025. I am indebted to the incredibly talented and dedicated VITAL team (pictured) and our commercial partners at Accession Therapeutics for delivering.
www.cardiff.ac.uk/news/view/29...
1
5
2
reposted by
Dr Bayliss
Alan Parker
about 2 months ago
Special thanks to
@cancerwales.bsky.social
and
@cancerresearchuk.org
who funded the early work on the development of this agent, and without which this agent would never have been created.
loading . . .
First patient recruited in clinical trial using cancer-targeting virus
The ATTEST trial is using a pioneering virus technology to infect cancer cells.
https://www.cardiff.ac.uk/news/view/2987115-first-patient-recruited-in-clinical-trial-using-cancer-targeting-virus
0
1
1
reposted by
Dr Bayliss
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies. Interested in contributing? Please submit an abstract to
app.jove.com/methods-coll...
loading . . .
JoVE Methods Collections
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
https://app.jove.com/methods-collections
6 months ago
0
0
1
Very excited our paper describing the development of a precision Virotherapy directly delivering bispecific molecules to tumour cells is in it's final polished form!
www.cell.com/molecular-th...
loading . . .
An αvβ6-specific virotherapy expressing bispecific immune cell activators induces immune cell activation to mediate tumor cell death
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in immune...
https://www.cell.com/molecular-therapy-family/oncology/fulltext/S2950-3299(25)00086-4?rss=yes&utm_source=dlvr.it&utm_medium=bluesky
6 months ago
0
1
1
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies. Interested in contributing? Please submit an abstract to
app.jove.com/methods-coll...
loading . . .
JoVE Methods Collections
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
https://app.jove.com/methods-collections
6 months ago
0
0
1
reposted by
Dr Bayliss
Dr Ricky Frazer
9 months ago
0
4
2
reposted by
Dr Bayliss
Alan Parker
10 months ago
Well, this is exciting, and has been a long time in the making. Many thanks to the many, many exceptional authors for their expert contributions. Would make a lovely Easter gift....(who needs chocolate eggs, right...?)
2
6
3
reposted by
Dr Bayliss
Alan Parker
7 months ago
Congratulations to
@gw4biomeddtp.bsky.social
@atwales.bsky.social
funded PhD student Rosie Mundy, presenting her groundbreaking structural and transcriptomic analysis of Ad10 today at the International Adenovirus Meeting at
@cardiffunilib.bsky.social
centre for student life.
0
9
3
reposted by
Dr Bayliss
Molecular Therapy Family of Journals
7 months ago
loading . . .
An αvβ6 specific precision virotherapy expressing bispecific immune cell activators induces immune cell activation and mediates tumour cell death.
Virotherapies can deliver anti-cancer therapeutics directly to tumours. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumour cells resulting in immune cell activation and tumour cell killing. Combination cancer therapy has potential to enhance regression of solid tumours in a targeted manner improving on current approaches.
http://dlvr.it/TLZ14K
0
2
2
reposted by
Dr Bayliss
Superbugs 🦠🔬🏫🧒🏽
7 months ago
Wait until you see our own pop-up shop that is going to open directly opposite the Oasis merch store on 7th July. 👉🏼
www.superbugs.online/pop-up-2025
@visitcardiff.bsky.social
0
9
5
you reached the end!!
feeds!
log in
